C. O'shaughnessy

发表

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

E. Tuzcu, P. Schoenhagen, S. Nissen, 2005 .

Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial.

C. O'shaughnessy, D. Holmes, J. Popma, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long‐term (5‐year) clinical evaluation of the Resolute zotarolimus‐eluting coronary stent: The RESOLUTE US clinical trial

A. Yeung, M. Leon, L. Mauri, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Frequency and Clinical Consequences Associated With Sidebranch Occlusion During Stent Implantation Using Zotarolimus-Eluting and Paclitaxel-Eluting Coronary Stents

A. Kirtane, M. Leon, L. Mauri, 2009, Circulation. Cardiovascular interventions.

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

G. Stone, S. Ellis, C. O'shaughnessy, 2004, The New England journal of medicine.

The StarClose® vascular closure system: Interventional results from the CLIP study

C. O'shaughnessy, J. Hermiller, C. Simonton, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-Term Benefit of the TAXUS Liberté Stent in Small Vessels and Long Lesions

G. Stone, C. O'shaughnessy, J. Ormiston, 2011 .

educed Risk of Restenosis in Small Vessels and educed Risk of Myocardial Infarction in Long Lesions ith the New Thin-Strut TAXUS Liberté Stent-Year Results From the TAXUS ATLAS Program ark

C. O'shaughnessy, J. Popma, J. Ormiston, 2008 .

843-4 Reduction in late loss and restenosis in patients with small vessels treated with the slow rate-release, polymer-based paclitaxel-eluting stent: Results from TAXUS-IV

G. Stone, S. Ellis, C. O'shaughnessy, 2004 .

elationship Between Angiographic ate Loss and Target Lesion evascularization After Coronary Stent Implantation

C. O'shaughnessy, J. Popma, J. Lasala, 2005 .

A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch

J. Moses, M. Leon, G. Weisz, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.

G. Stone, G. Dangas, S. Goldberg, 2011, JACC. Cardiovascular interventions.

olymer-Based Paclitaxel-Eluting Stents educe In-Stent Neointimal Tissue Proliferation

G. Stone, C. O'shaughnessy, D. Cox, 2005 .

Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization.

C. O'shaughnessy, J. Hermiller, C. Simonton, 2005, The Journal of invasive cardiology.

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.

Paul Schoenhagen, John Tsai, Tim Crowe, 2005, The New England journal of medicine.

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Jeffrey W Moses, Martin B Leon, P. Teirstein, 2003, The New England journal of medicine.

Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.

G. Stone, N. Weissman, S. Ellis, 2005, Journal of the American College of Cardiology.

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

Gregg W Stone, G. Stone, S. Ellis, 2005, JAMA.

Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary Lesions: Angiographic Follow-Up of the DELIVER Clinical Trial

G. Stone, W. O’Neill, M. Leon, 2004, Circulation.

One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial

Gregg W Stone, G. Stone, S. Ellis, 2004, Circulation.

Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.

G. Stone, S. Ellis, R. Mehran, 2006, Journal of the American College of Cardiology.

Procedural and late outcomes following MULTI-LINK DUET coronary stent deployment.

J. Moses, C. O'shaughnessy, D. Kereiakes, 1999, The American journal of cardiology.

Randomized Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenoses

Larry S. Dean, Martin B. Leon, Jeffrey J. Popma, 2000, Circulation.

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.

G. Stone, S. Ellis, L. Satler, 2006, JAMA.

Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials).

D. Baim, A. Lansky, C. O'shaughnessy, 2000, The American journal of cardiology.

Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.

G. Stone, S. Ellis, C. O'shaughnessy, 2005, Journal of the American College of Cardiology.

Comparison of PRE-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial).

P. Fitzgerald, D. Baim, C. O'shaughnessy, 2001, The American journal of cardiology.

Treated Diabetes Mellitus: Results From the TAXUS ATLAS Program TAXUS Liberté Attenuates the Risk of Restenosis in Patients With Medically

C. O'shaughnessy, J. Popma, J. Ormiston, 2011 .

TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.

N. Weissman, E. Mahmud, D. Baim, 2009, JACC. Cardiovascular interventions.

Safety and efficacy of renal artery stenting following suboptimal renal angioplasty for de novo and restenotic ostial lesions: results from a nonrandomized, prospective multicenter registry.

C. O'shaughnessy, J. Laird, R. Zierler, 2010, Journal of vascular and interventional radiology : JVIR.

A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.

R. Whitbourn, A. Yeung, P. Fitzgerald, 2012, International journal of cardiology.

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.

P. Fitzgerald, A. Kirtane, M. Leon, 2010, Journal of the American College of Cardiology.

Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

P. Fitzgerald, A. Kirtane, M. Leon, 2009, JACC. Cardiovascular interventions.

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

P. Fitzgerald, M. Leon, L. Mauri, 2006, Journal of the American College of Cardiology.

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

M. Pfeffer, C. Grines, R. D. de Winter, 2014, European heart journal.

Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).

G. Stone, S. Ellis, D. Baim, 2009, JACC. Cardiovascular interventions.

Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries.

M. Leon, D. Baim, A. Lansky, 2001, The American journal of cardiology.

omparison of Zotarolimus-Eluting nd Sirolimus-Eluting Stents in Patients ith Native Coronary Artery Disease Randomized Controlled Trial avid

M. Leon, L. Mauri, C. O'shaughnessy, 2006 .

A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.

Mitchell W. Krucoff, Vic Hasselblad, William Wijns, 2008, Journal of the American College of Cardiology.

Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.

D. Baim, C. O'shaughnessy, J. Popma, 2008, JACC. Cardiovascular interventions.

The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions.

M. Bell, M. Buchbinder, A. Lansky, 2000, The American journal of cardiology.

Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.

G. Stone, S. Ellis, K. Kent, 2008, European heart journal.

Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials.

R. Whitbourn, A. Yeung, P. Fitzgerald, 2010, Circulation journal : official journal of the Japanese Circulation Society.

Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.

D. Baim, C. O'shaughnessy, J. Popma, 2007, Journal of the American College of Cardiology.

Long-term benefit of the TAXUS Liberté stent in small vessels and long lesions. TAXUS ATLAS program.

G. Stone, C. O'shaughnessy, J. Ormiston, 2011, Circulation journal : official journal of the Japanese Circulation Society.

The CLOSER trial: a multi‐center study on the clinical safety and effectiveness of CloserTM VSS, a novel resorbable transfemoral vascular access sealing system

C. O'shaughnessy, Ping-Yu Liu, R. Gammon, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.

P. Fitzgerald, A. Kirtane, M. Leon, 2010, Journal of the American College of Cardiology.

One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial

G. Stone, S. Ellis, C. O'shaughnessy, 2004, Circulation.

A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch

J. Moses, M. Leon, G. Weisz, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).

P. Fitzgerald, P. Yock, R. Wilensky, 2006, The American journal of cardiology.